Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population

Gynecologic Oncology

Volumn 102, Issue 2, 2006, Pages 230-235

  Lizano, Marcela ^a   De la Cruz Hernández, Erick ^a   Carrillo García, Adela ^a   García Carrancá, Alejandro ^a   Ponce de Leon Rosales, Sergio ^b   Dueñas González, Alfonso ^a   Hernández Hernández, Dulce Maria ^c   Mohar, Alejandro ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Cervical cancer; HPV; Intratypic variation

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MEXICO; POPULATION RESEARCH; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR CELL; UNDIFFERENTIATED CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS VIRULENCE;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MEXICO; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 33746018323     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.12.002     Document Type: Article

References (36)

1. World Health Report 2004: Changing History Statical annex. World Health Organization, http//www.who.int/whr/2004/en/index.htm.
2. Registro Histopatológico de Neoplasias Malignas RHNM. Dirección General de Epidemiología S.S.A. México. 2002.
3. Walboomers J., Jacobs M., Manos M., Bosch F.X., Ummer KJ.A., and Shan K.V. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 1 (1999) 12-19
4. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 4 (2002) 244-265
5. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 1 (2004) 17-27
6. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 6 (2003) 518-527
7. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88 1 (2003) 63-73
8. Walboomers J.M., and Meijer C.J. Do HPV-negative cervical carcinomas exist?. J. Pathol. 181 3 (1997) 253-254
9. Kjaer S.K., van den Brule A.J., Bock J.E., Poll P.A., Engholm G., Sherman M.E., et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?. Cancer Epidemiol. Biomarkers Prev. 6 10 (1997) 799-805
10. Lazcano-Ponce E., Herrero R., Munoz N., Cruz A., Shah K.V., Alonso P., et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer 91 3 (2001) 412-420
11. Wright Jr. T.C., and Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. N. Engl. J. Med. 348 6 (2003) 489-490
12. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170 5 (1994) 1077-1085
13. Hecht J.L., Kadish A.S., Jiang G., and Burk R.D. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer 60 3 (1995) 369-376
14. Lizano M., Berumen J., Guido M.C., Casas L., and Garcia-Carranca A. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J. Natl. Cancer Inst. 89 16 (1997) 1227-1231
15. Xi L.F., Koutsky L.A., Galloway D.A., Kuypers J., Hughes J.P., Wheeler C.M., et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89 11 (1997) 796-802
16. Zehbe I., Wilander E., Delius H., and Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58 4 (1998) 829-833
17. Berumen J., Ordoñez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 93 17 (2001) 1325-1330
18. De Boer M.A., Peters L.A., Aziz M.F., Siregar B., Cornain S., Vrede M.A., et al. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int. J. Cancer 114 3 (2005) 422-425
19. Stoppler M.C., Ching K., Stoppler H., Clancy K., Schlegel R., and Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 70 10 (1996) 6987-6993
20. Kammer C., Warthorst U., Torrez-Martinez N., Wheeler C.M., and Pfister H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J. Gen. Virol. 81 Pt 8 (2000) 1975-1981
21. Chakrabarti O., Veeraraghavalu K., Tergaonkar V., Liu Y., Androphy E.J., Stanley M.A., et al. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J. Virol. 78 11 (2004) 5934-5945
22. Burger R.A., Monk B.J., Kurosaki T., Anton-Culver H., Vasilev S.A., Berman M.L., et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J. Natl. Cancer Inst. 88 19 (1996) 1361-1368
23. Im S.S., Wilczynski S.P., Burger R.A., and Monk B.J. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin. Cancer Res. 9 11 (2003) 4145-4150
24. Davey D.D. Cervical cytology classification and the Bethesda system. Cancer J. 9 5 (2003) 327-334
25. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
26. Resnick R.M., Cornelissen M.T., Wright D.K., Eichinger G.H., Fox H.S., ter Schegget J., and Manos M.M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. 82 18 (1990) 1477-1484
27. Ong C.K., Chan S.Y., Campo M.S., Fujinaga K., Mavromara-Nazos P., Labropoulou V., et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 67 11 (1993) 6424-6431
28. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71 3 (1997) 2463-2472
29. Cytel software Corp: StatXact 4 for windows. Statistical software for exact nonparametric inference. Cambridge, 1999.
30. Carrillo A., Mohar A., Meneses A., Frias-Mendivil M., Solorza G., and Lizano M. Usefulness of combining universal oligonucleotides in detecting human papillomavirus in cervical cancer and premalignant lesions. Salud Publica Mex. 46 1 (2004) 7-15
31. Schlecht N.F., Kulaga S., Robitaille J., Ferreira S., Santos M., Miyamura R.A., et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286 24 (2001) 3106-3114
32. Gonzalez-Losa M.R., Laviada Mier y Teran M.A., Puerto-Solis M., and Garcia-Carranca A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J. Clin. Virol. 29 2 (2004) 95-98
33. Villa L.L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 81 Pt 12 (2000) 2959-2968
34. Ordoñez R.M., Espinosa A.M., Sanchez-Gonzalez D.J., Armendariz-Borunda J., and Berumen J. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J. Gen. Virol. 85 Pt 6 (2004) 1433-1444
35. Sichero L., Franco E.L., and Villa L.L. Different P105 promoter activities among natural variants of human papillomavirus type 18. J. Infect. Dis. 191 5 (2005) 739-742
36. De la Cruz-Hernández E., García-Carrancá A., Mohar-Betancourt A., Dueñas-González A., Contreras-Paredes A., Pérez-Cárdenas E., et al. Differential Splicing of E6 within human papillomavirus type 18 variants and functional consequences. J. Gen. Virol. 86 (2005) 2459-2468